Table I Index
Table of Contents
|
Table I - 46 LaPorte Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 497 | 371.6 | 270 | 452.9 | 227 | 310.7 |
| Oral cavity and pharynx | 15 | 12.2** | 11 | 19.0** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | 6 | 4.7** | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 98 | 69.1 | 50 | 82.9 | 48 | 58.8 |
| Esophagus | 9 | 7.0** | 6 | 10.7** | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 47 | 33.0 | 30 | 49.7 | 17 | 19.6** |
| Rectum and rectosigmoid | 20 | 13.7 | 6 | 9.3** | 14 | 18.7** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | 10 | 7.1** | * | # | 6 | 7.3** |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 5 | 3.5** | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 84 | 65.7 | 61 | 104.9 | 23 | 34.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 11 | 9.3** | 7 | 12.6** | * | # |
| Lung and bronchus | 71 | 54.8 | 53 | 90.7 | 18 | 26.1** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 16 | 12.4** | 10 | 16.1** | 6 | 8.6** |
| Melanoma of the skin | 14 | 11.0** | 9 | 14.8** | 5 | 7.0** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 59 | 44.1 | * | # | 59 | 84.4 |
| Female genital system | 36 | 26.1 | -- | -- | 36 | 50.0 |
| Cervix uteri | 6 | 3.6** | -- | -- | 6 | 7.6** |
| Corpus uteri | 16 | 11.9** | -- | -- | 16 | 22.1** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 9 | 7.3** | -- | -- | 9 | 14.3** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 83 | 60.2 | 83 | 135.7 | -- | -- |
| Prostate gland | 80 | 58.1 | 80 | 131.7 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 44 | 32.5 | 28 | 46.3 | 16 | 19.3** |
| Urinary bladder | 29 | 20.7 | 18 | 29.6** | 11 | 12.3** |
| Kidney and renal pelvis | 13 | 10.4** | 9 | 15.1** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 5 | 4.5** | * | # | * | # |
| Brain | 5 | 4.5** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 24 | 18.7 | 10 | 16.4** | 14 | 19.4** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 23 | 17.4 | 9 | 13.9** | 14 | 19.4** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 11 | 8.4** | 6 | 11.1** | 5 | 6.3** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 11 | 8.1** | 5 | 8.8** | 6 | 7.2** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||